Torshälla, Sweden – 9 May 2025 – The Board of Directors of Stille AB (“Stille”), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025.
With a distinguished background in the medical technology sector and a proven track record of strategic leadership and of driving growth organically as well as through M&A in both US and European markets, Mr. Berthelsen brings a wealth of experience to Stille. He succeeds Torbjörn Sköld, who has been the Chief Executive Officer since 20 Mar 2023.
Over the past 20 years, Ulrik Berthelsen has held senior international positions, primarily at Coloplast and Atos Medical, where he has led transformative initiatives delivering strong growth and innovation. His appointment marks an exciting new chapter for Stille, as the company continues to expand its global presence and reinforce its commitment to surgical precision and patient care.
"We are thrilled to welcome Ulrik to Stille," said Jón Sigurdsson, recently appointed Chairman of the Board of Directors and former long-time CEO of Össur/Embla Medical. "His deep industry knowledge, visionary leadership, and customer-focused approach will be instrumental in driving the next phase of our growth and innovation."
Mr. Berthelsen commented: “I am honored to join Stille, a company with a remarkable heritage and strong reputation for quality and innovation. I look forward to working with the team at Stille to build on this foundation and accelerate our progress in delivering value to surgeons and patients worldwide.”
The Board of Directors expresses its sincere gratitude to Torbjörn Sköld for his contributions to the company over the past two years.